Deep vein thrombosis and stress ulcer prophylaxis in the intensive care unit

Journal of Pharmacy Practice

Volumn 24, Issue 1, 2011, Pages 78-88

  Goodwin, Corey M ^a   Hoffman, Jason A ^a  

^a CARILION CLINIC   (United States)

Author keywords

Anticoagulants; Deep vein thrombosis prophylaxis; Gastrointestinal agents; Stress ulcer prophylaxis

Indexed keywords

ANTACID AGENT; CIMETIDINE; DALTEPARIN; ENOXAPARIN; FAMOTIDINE; FIBRINOGEN; FONDAPARINUX; HEPARIN; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROCORTISONE; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN; OMEPRAZOLE; PLACEBO; RANITIDINE; SUCRALFATE;

ANTICOAGULATION; ARTICLE; ARTIFICIAL VENTILATION; BLEEDING; CONSTIPATION; CONTINUOUS INFUSION; CORTICOSTEROID THERAPY; DEEP VEIN THROMBOSIS; DIARRHEA; DOSAGE SCHEDULE COMPARISON; DRUG EFFICACY; DRUG TOLERABILITY; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMAN; HYPERCALCEMIA; HYPERMAGNESEMIA; HYPERPHOSPHATEMIA; INTENSIVE CARE UNIT; KIDNEY FAILURE; NASOGASTRIC TUBE; NEUROTOXICITY; OBESITY; PATHOGENESIS; RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; RISK FACTOR; STRESS ULCER; THROMBOCYTOPENIA; THROMBOSIS PREVENTION; TOTAL PARENTERAL NUTRITION; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

EID: 79953878887     PISSN: 08971900     EISSN: 15311937     Source Type: Journal    
DOI: 10.1177/0897190010393851     Document Type: Article

References (89)

1. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism. Chest. 2008;133:381S-453S.
2. Haines ST, Witt DM, Nutescu EA. Venous thromboembolism. In: DiPiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM, eds. Pharmacotherapy: A Pathopsyiologic Approach, 7th ed. Boston: McGraw-Hill;2008:331-371.
3. Crowther MA, Cook DJ, Griffith LE, et al. Deep venous thrombosis: Clinically silent in the intensive care unit. J Crit Care. 2005;20:334-340. (Pubitemid 41727591)
4. Ibrahim EH, Iregui M, Prentice D, et al. Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med. 2002;30:771-774. (Pubitemid 34297792)
5. Cook D, Crowther M, Meade M, et al. Deep venous thrombosis in medial-surgical critically ill patients: Prevalence, incidence, and risk factors. Crit Care Med. 2005;33:1565-1571. (Pubitemid 40980613)
6. Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA. 1995;274:335-337.
7. Product Information: Arixtra®, fondaparinux sodium injection. GlaxoSmithKline, Research Triangle Park, NC, 2010.
8. Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med. 1982;10:448-450.
9. Fraisse F, Holzapfel L, Coulaud J, et al. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. Am J Respir Crit Care Med. 2000;161:1109-1114. (Pubitemid 30243816)
10. Cook DJ, Rocker G, Meade M, et al. Prophylaxis of thromboembolism in critical care (PROTECT) trial: A pilot study. J Crit Care. 2005;20:364-372. (Pubitemid 41727596)
11. King CS, Holley AB, Jackson JL, et al. Twice vs three times daily heparin dosing for thromboembolism prophylaxis in the general medical population: A metaanalysis. Chest. 2007;131:507-516. (Pubitemid 46280413)
12. Product Information: Fragmin®, dalteparin sodium injection.
13. Product Information: Lovenox®, enoxaparin sodium injection. sanofi-aventis US, LLC, Bridgewater, NJ, 2009.
14. Robinson S, Zincuk A, Strøm T, et al. Enoxaparin, effective dosage for intensive care patients: Double-blinded, randomised clinical trial. Crit Care. 2010;14:R41.
15. Haas CE, Nelson JL, Raghavendran K, et al. Pharmacokinetics and pharmacodynamics of enoxaparin in multiple trauma patients. J Trauma. 2005;59:1336-1344.
16. Limpus A, Chaboyer W, McDonald E, et al. Mechanical thromboprophylaxis in critically ill patients: A systematic review and meta-analysis. Am J Crit Care. 2006;15:402-412. (Pubitemid 44859181)
17. The perioperative management of antithrombotic therapy. Chest. 2008;133:299S-339S.
18. Cook DJ, Crowther MA. Thromboprophylaxis in the intensive care unit: Focus on medical-surgical patients. Crit Care Med. 2010;38[supp.]:S76-S82.
19. Rabbat CG, Cook DJ, Crowther MA, et al. Dalteparin thromboprophylaxis for critically ill medical-surgical patients with renal insufficiency. J Crit Care. 2005;20:357-363. (Pubitemid 41727595)
20. Cook D, Douketis J, Meade M, et al. Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: Prevalence, incidence, and risk factors. Crit Care. 2008;12: R32.
21. Kucher N, Leizorovicz A, Vaitkus PT, et al. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients. Arch Intern Med. 2005;165:341-5. (Pubitemid 40216291)
22. Cook DJ, Douketis J, Arnold D, et al. Bleeding and venous thromboembolism in the critically ill with emphasis on patients with renal insufficiency. Curr Opin Pulm Med. 2009;15:455-462.
23. Douketis J, Cook D, Meade M, et al. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with the low-molecular-weight heparin dalteparin. Arch Intern Med. 2008;168:1805-1812.
24. Robertson MS, Cade JF, Clancey RL. Helicobacter pylori infection in intensive care: Increased prevalence and a new nosocomial infection. Crit Care Med. 1999;27:1276-80. (Pubitemid 29379364)
25. Cook DJ, Reeve BK, Guyatt GH, et al. Stress ulcer prophylaxis in critically ill patients: Resolving discordant meta-analyses. JAMA. 1996;275:308-314.
26. Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastrointestinal bleeding in critically ill patients. N Engl J Med. 1994;330: 377-381. (Pubitemid 24045653)
27. Ben-Menachem T, Fogel R, Patel RV, et al. Prophylaxis for stress-related gastric hemorrhage in the medical intensive care unit. Ann Intern Med. 1994;121:568-575.
28. Cook DJ, Griffith LE, Walter SD, et al. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care. 2001;5: 368-375. (Pubitemid 34130340)
29. Tsiotos GG, Mullany CJ, Zietlow S, et al. Abdominal complications following cardiac surgery. Am J Surg. 1994;167:553-557. (Pubitemid 24332510)
30. Cho CH, Koo MW, Garg GP, et al. Stress-induced gastric ulceration: Its aetiology and clinical implications. Scand J Gastroenterol. 1992;27:257-262.
31. Bowen JC, Fleming WH, Thompson JC. Increased gastrin release following penetration central nervous system injury. Surgery. 1974;75:720-724.
32. Watts CC, Clark K. Gastric acidity in the comatose patient. J Neurosurg. 1969;30:107-109.
33. O'Neill JA. The influence of thermal burns on gastric acid secretion. Surgery. 1970;67:267-271.
34. Gudeman SK, Wheeler CB, Miller JD, et al. Gastric secretory and mucosal injury response to severe head trauma. Neurosurgery. 1983;12:175-179. (Pubitemid 13145187)
35. Mutlu GM, Mutlu EA, Factor P. GI complications in patients receiving mechanical ventilation. Chest. 2001;119:1222-1241. (Pubitemid 32679452)
36. Maynard N, Bihari DJ, Beale R, et al. Assessment of splanchnic oxygenation by gastric tonometry in patients with acute circulatory failure. JAMA. 1993;270:1203-1210. (Pubitemid 23262350)
37. Pimentel M, Roberts DE, Bernstein CN, et al. Clinically significant gastrointestinal bleeding in critically ill patients in an era of prophylaxis. Am J Gastroenterol. 2000;95: 2801-2806.
38. Levin NG, Thorn SE, Lindberg G, et al. Dopamine reduces gastric tone in a dose-related manner. Acta Anaesthesiol Scand. 1999;43: 722-725. (Pubitemid 29362046)
39. Halm U, Halm F, Thein D, et al. Helicobacter pylori infection: A risk factor for upper gastrointestinal bleeding after cardiac surgery? Crit Care Med. 2000;28:110-113. (Pubitemid 30091038)
40. van der Voort PH, van der Hulst RW, Zandstra DF, et al. Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury. Intensive Care Med. 2001;27:68-73. (Pubitemid 32208971)
41. Scuster DP, Rowley H, Feinstein S, et al. Prospective evaluation of the risk of upper gastrointestinal bleeding after admission to a medical intensive care unit. Am J Med. 1984;76:623-630. (Pubitemid 14127552)
42. Estruch R, Pedrol E, Castelles A, et al. Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward. Scand J Gastroenterol. 1991;26:819-826.
43. Shuman RB, Schuster DP, Zuckerman GR. Prophylactic therapy for stress ulcer bleeding: A reappraisal. Ann Intern Med. 1987;106:562-567. (Pubitemid 17095045)
44. Martin LF, Booth FV, Reines D, et al. Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg. 1992;215:332-337.
45. Layon AJ, Florete O, Day AL, et al. The effect of duodenojejunal alimentation on gastric pH and hormones in intensive care unit patients. Chest. 1991;99:695-702.
46. Pingleton SK, Hadzima SK. Enteral alimentation and gastrointestinal bleeding in mechanically ventilated patients. Crit Care Med. 1983;11:13-16. (Pubitemid 13032285)
47. Ben-Menachem T, McCarthy BD, Fogel R, et al. Prophylaxis for stress-related gastrointestinal hemorrhage: A cost effectiveness analysis. Crit Care Med. 1996;24:338-345. (Pubitemid 26065346)
48. Ruiz-Santana S, Ortiz E, Gonzalez B, et al. Stress-induced gastro-duodenal lesions and total parenteral nutrition in critically ill patients: Frequency, complications, and the value of prophylactic treatment: A prospective, randomized study. Crit Care Med. 1991;19:887-891.
49. McCarthy DM. Sucralfate. N Engl J Med. 1991;325:1017-1025.
50. Tryba M, Cook D. Current guidelines on stress ulcer prophylaxis. Drugs. 1997;54:581-596. (Pubitemid 27464156)
51. Bonten MJ, Gaillard CA, van der Geest S, et al. The role of intragastric acidity and stress ulcus prophylaxis on colonization and infection in mechanically ventilated patients. A stratified, randomized, double-blind study of sucralfate versus antacids. Am J Resp Crit Care Med. 1995;152:1825-1834.
52. Prod'hom G, Leuenberger P, Koerfer J, et al. Nosocomial pneumonia in mechanically ventilated patients receiving antacid, ranitidine, or sucralfate as prophylaxis for stress ulcer. A randomized, controlled trial. Ann Internal Med. 1994;120:653-662. (Pubitemid 24106177)
53. Thomason MH, Payseur ES, Hakenewerth AM, et al. Nosocomial pneumonia in ventilated trauma patients during stress ulcer prophylaxis with sucralfate, antacid, and ranitidine. J Trauma. 1996;41:503-508. (Pubitemid 26318082)
54. Cook D, Guyatt G, Marshall J, et al. A comparison of sucralfate and ranitidine for the prevention of upper gastrointestinal bleeding in patients requiring mechanical ventilation. N Engl J Med. 1998;338:791-797. (Pubitemid 28135985)
55. Hastings PR, Skillman JJ, Bushnell LS, et al. Antacid titration in the prevention of acute gastrointestinal bleeding: A controlled, randomized trial in 100 critically ill patients. N Engl J Med. 1978;298:1041-1045. (Pubitemid 8362282)
56. Feldman M, Burton ME. Histamine2-receptor antagonists. Standard therapy for acid-peptic diseases. N Engl J Med. 1990;323: 1672-1680.
57. Baghaie AA, Mojtahedzadeh M, Levine RL, et al. Comparison of the effects of intermittent administration and continuous infusion of famotidine on gastric pH in critically ill patients: Results of a prospective randomized, crossover study. Crit Care Med. 1995;23:687-691.
58. Erstad BL, Barletta JF, Jacobi J, et al. Survey of stress ulcer prophylaxis. Crit Care. 1999;3:145-149. (Pubitemid 30004542)
59. Netzer P, Gaia C, Sandoz M, et al. Effect of repeated injection and continuous infusion of omeprazole and ranitidine on intragastric pH over 72 hours. Am J Gastroenterol. 1999;94: 351-357. (Pubitemid 29084652)
60. Merki HS, Wilder-Smith CH. Do continuous infusions of omeprazole and ranitidine retain their effect with prolonged dosing? Gastroenterology. 1994;106:60-64. (Pubitemid 24011865)
61. Cook DJ, Witt LA, Cook RJ, et al. Stress ulcer prophylaxis in the critically ill: A meta-analysis. Am J Med. 1991;91: 519-527.
62. Lasky MR, Metzler MH, Phillips JO. A prospective study of omeprazole suspension to prevent clinically significant gastrointestinal bleeding from stress ulcers in mechanically ventilated trauma patients. J Trauma. 1998;44:527-533. (Pubitemid 28153107)
63. Phillips, Metzler MH, Palmieri TL, et al. A prospective study of simplified omeprazole suspension for the prophylaxis of stress-related mucosal damage. Crit Care Med. 1996;24: 1793-1800. (Pubitemid 26382920)
64. Levy MG, Seelig CB, Robinson NJ, et al. Comparison of omeprazole and ranitidine for stress ulcer prophylaxis. Dig Dis Sci. 1997;42:1255-1259. (Pubitemid 27343453)
65. Conrad SA, Gabrielle A, Margolis B, et al. Randomized, double-blind comparison of immediate-release omeprazole suspension versus intravenous cimetidine for the prevention of gastrointestinal bleeding in critically ill patients. Crit Care Med. 2005;33: 760-765.
66. Moore JG, Coburn JW, Sanders MC, et al. Effects of sucralfate and ranitidine on aluminum concentrations in elderly volunteers. Pharmacotherapy. 1995;15:742-746.
67. Burgess E, Muruve D, Audette R. Aluminum absorption and excretion following sucralfate therapy in chronic renal insufficiency. Am J Med. 1992;92:471-475.
68. Anderson W, Weatherstone G. Esophageal medication bezoar in a patient receiving enteral feedings and sucralfate. Am J Gastroenterol. 1989;84:205-206. (Pubitemid 19060763)
69. Guay DR. The role of fluoroquinolones. Pharmacotherapy. 1992;12:71S-85S.
70. Marcuarad SP, Perkins AM. Clogging of feeding tubes. J Parenter Enteral Nutr. 1988;12:403-405.
71. Aymard JP, Aymard B, Netter P, et al. Haematological adverse effects of histamine H2-receptor antagonists. Med Toxicol. 1988;3:430-438.
72. Wade EE, Rebuck JA, Healey ME, et al. H(2) antagonist-induced thrombocytopenia: Is this a real phenomenon? Intensive Care Med. 2002;28:459-465. (Pubitemid 34328031)
73. Cawley MJ, Wittbrodt ET, Boyce EG, et al. Potential risk factors associated with thrombocytopenia in a surgical intensive care unit. Pharmacotherapy. 1999;19:108-113. (Pubitemid 29031534)
74. Welage LS, Barardi RR. Drug interactions with antiulcer agents: Considerations in the treatment of acid-peptic disease. J Pharmacy Practice. 1994;7:177-195.
75. Puff MR, Carey WD. The effect of cimetidine on cyclosporine A levels in liver transplant recipients: A preliminary report. Am J Gastroenterol. 1992;87:287-291.
76. Food and Drug Administration. Early communication about an ongoing review of clopidogrel bisulfate (marketed as Plavix). www.fda.gov/Drugs/DrugSafety/ PostmarketDrugSafetyInformationforPatientsandProviders/ DrugSafetyInformationforHeathcareProfessionals/ucm079520.htm (accessed 2010 May 1).
77. Last EJ, Sheehan AH. Review of recent evidence: Potential interaction between clopidogrel and proton pump inhibitors. Am J Health-Syst Pharm. 2009;55:2117-2122.
78. Messori A, Trippoli S, Vaiani M, et al. Bleeding and pneumonia in intensive care patients given ranitidine and sucralfate for prevention of stress ulcer: Meta-analysis of randomised controlled trials. BMJ. 2000;321:1103-1106.
79. Torres A, El-Ebiary N, Soler C, et al. Stomach as a source of colonization of the respiratory tract during mechanical ventilation: Association with ventilator-associated pneumonia. Eur Respir J. 1996;9:1729-1735. (Pubitemid 26271161)
80. Ibrahim EH, Tracy L, Hill C, et al. The occurrence of ventilator-associated pneumonia in a community hospital. Chest. 2001;120: 555-561. (Pubitemid 32881275)
81. Miano TA, Reichert MG, Houle TT, et al. Nosocomial pneumonia risk and stress ulcer prophylaxis:A comparison of pantoprazole vs. ranitidine in cardiothoracic surgery patients. Chest. 2009;136: 440-447.
82. Bonten MJ, Guillard CA, de Leeuw PW, et al. Role of colonization of the upper intestinal tract in the pathogenesis of ventilator-associated pneumonia. Clin Infect Dis. 1997;24:309-319. (Pubitemid 27096781)
83. DePriest JL. Stress ulcer prophylaxis: Do critically ill patients need it? Postgrad Med. 1995;98:159-161.
84. Martin LF, Booth FV, Reines HD, et al. Stress ulcers and organ failure in intubated patients in surgical intensive care units. Ann Surg. 1992;215:332-337.
85. Lam NP, Le PD, Crawford SY, et al. National Survey of stress ulcer prophylaxis. Crit Care Med. 1999;27:98-103. (Pubitemid 29052822)
86. Barletta JF, Erstad BL, Fortune JB. Stress ulcer prophylaxis in trauma patients. Crit Care. 2002;6:526-530. (Pubitemid 35414585)
87. Navab F, Steingrub J. Stress ulcer: Is routine prophylaxis necessary? Am J Gastroenterol. 1995;90:708-712.
88. Devlin JW, Ben-Menachem T, Ulep SK, et al. Stress ulcer prophylaxis in medical ICU patients: Annual utilization in relation to the incidence of endoscopy-proven stress ulceration. Ann Pharmacother. 1998;32:869-874. (Pubitemid 28420322)
89. Faisy C, Guerot E, Diehl JL, et al. Clinically significant gastrointestinal bleeding in critically ill patients with and without stress ulcer prophylaxis. Intensive Care Med. 2003;29: 1306-1313. (Pubitemid 37041160)